parallel assessment of quality-by-design applications

• European Union
• Government
• Healthcare
• Pharma & Biotech
• Science

EMA and US FDA published joint first conclusions of parallel assessment of quality-by-design applications (QbD)

29-8-2013 — /EuropaWire/ — The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer document that…